Artificial intelligence

4 February 2019

Dubai World Trade Centre

Overview:

Theme: Harnessing the power of AI to advance medical efficiency

With over 65% of the GCC region ready to support the use of Artificial Intelligence (AI) as an integral healthcare solution1, it is a pleasure to welcome the highly anticipated and brand new Artificial Intelligence conference to MEDLAB 2019.

Across the entire healthcare field, AI presents profound and promising prospects for improved efficiencies in relation to streamlined and automated care provision and services.

The medical laboratory particularly demonstrates the transformative effect of AI, with improved quality of care already being delivered. The Artificial Intelligence conference comprehensively explores the impact of AI within this field, as regional and international experts explore different applications of AI in healthcare through practical and insightful interactive presentations.

Key topics:

  • The future of the medical laboratory and development of AI-powered healthcare systems
  • Global approaches to AI within the lab
  • AI in healthcare research and diagnostics
  • Ethical considerations

Benefits of attending:

  • Explore the potential for AI to transform the medical laboratory, considering the benefits and current challenges
  • Review the key technological breakthroughs currently trailblazing the AI field
  • Appraise how international hospitals are currently employing AI within their laboratories and analyse the effect on financial management, quality and efficiency
  • Review the ethical aspects surrounding AI utilisation

09:30

Opening remarks

Dr P. K Menon, Medical Director & COO, Thumbay Labs, Thumbay Group, Dubai, UAE

Dr Najat Rashid, Chief of Laboratory services, SKMCA, Ministry of Presidential Affair, Dubai, UAE

Session 1

The future of the medical laboratory and development of AI-powered healthcare systems

10:00

Keynote address: UAE to lead a healthcare revolution by 2031 by harnessing AI

Key speaker tbc

11:30

Revolutionising patient care through futuristic technologies

Key speaker tbc

11:00 Coffee Break


Session 2

Global approaches to AI within the lab

11:30

An introduction: AI and blockchain

Dr P. K Menon, Director, Laboratory Services, Director, The Center for Advanced Biomedical Research and Innovation (CABRI), Gulf Medical University (GMU), Thumbay Group, Ajman, UAE

12:00

Global approaches to AI: how disruptive technologies will affect the market and the laboratory workforce

Supreet Singh Manchanda, Managing General Partner, Raiven Capital, San Francisco, California

12:30

AI and health information technology transforming NHS care

Dr Harpreet S Sood, Associate Chief Clinical Information Officer, NHS England, Clinical Doctor, University College Hospital, London, United Kingdom

13:00 Lunch Break


Session 3

AI in healthcare research and diagnostics

14:00

Keynote plenary address: Saving lives with health data robots

Luis Menezes, Chief Executive Officer, Unilabs, Porto, Portugal

Jose Pedro Almeida, Director of Big Data Analytics and Machine Learning, São João Hospital Center, Porto, Portugal

15:00

Data science with 4 billion clinical laboratory results

Mark Hoffman, Chief Research Information Officer, Children’s Research Institute, Children’s Mercy Kansas City, Associate Professor, Biomedical and Health Informatics, Pediatrics, UMKC School of Medicine, Kansas City, Missouri, USA

15:30 Coffee Break


Session 4

Ethical considerations

16:00

AI, medical informatics and healthcare security

Dr (Lt Gen) CS Narayanan, VSM, President's Honorary Surgeon, Head, Department of Neurology, Manipal Hospitals, New Delhi, India

16:30

SALAMA: The medical laboratory and the DHA electronic medical record management

Dr Immanuel Azaad Moonesar, Assistant Professor of Health Policy, Health Policy Research Leader, MPA Program Coordinator, Mohammed Bin Rashid School of Government, President, Academy of International Business - MENA Chapter, Dubai, UAE

17:00

Closing keynote: Addressing the gaps among promises, achievements, and future potential

Professor Ahmed Morsy, Professor of Biomedical Engineering, Cairo University, Cairo,
Egypt
Chairman, Nebras Technology, Editor in Chief, IEEE Engineering in Medicine and Biology Society, New Jersey, USA 

17:00 End of conference

Chairs:

Dr P. K Menon, Medical Director & COO, Thumbay Labs, Thumbay Group, Dubai, UAE
Dr Najat Rashid, Chief of Laboratory services, SKMCA, Ministry of Presidential Affair, Dubai, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

Professor Ahmed Morsy, Professor of Biomedical Engineering, Cairo University, Cairo, Egypt, Chairman, Nebras Technology, Editor in Chief, IEEE Engineering in Medicine and Biology Society, New Jersey, USA

Dr (Lt Gen) CS Narayanan, VSM, President's Honorary Surgeon, Head, Department of Neurology, Manipal Hospitals, New Delhi, India 

Dr Harpreet S Sood, Associate Chief Clinical Information Officer, NHS England, Clinical Doctor, University College Hospital, London, United Kingdom

Dr Immanuel Azaad Moonesar, Assistant Professor of Health Policy, Health Policy Research Leader, MPA Program Coordinator, Mohammed Bin Rashid School of Government, President, Academy of International Business - MENA Chapter, Dubai, UAE

Jose Pedro Almeida, Director of Big Data Analytics and Machine Learning, São João Hospital Center, Porto, Portugal

Luis Menezes, Chief Executive Officer, Unilabs, Porto, Portugal

Mark Hoffman, Chief Research Information Officer, Children’s Research Institute, Children’s Mercy Kansas City, Associate Professor, Biomedical and Health Informatics, Pediatrics, UMKC School of Medicine, Kansas City, Missouri, USA


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: